“The driving forces behind the increase in cost are the same in all countries but are of different strengths. Chile has had a considerable improvement in biological results, clearly visible in costs. The Faroe Islands have lost some ground after experiencing larger challenges with lice and disease. Scotland and Canada have the highest costs, and while the increase has been moderate in Canada in recent years, it has been very large in Scotland,” said Nofima scientist Audun Iversen.